What is the Cervista HPV test? The Cervista HPV test, developed by Hologic, serves as a vital tool for identifying human papillomavirus (HPV) genetic material in cervical samples, aiding in the early detection of potential risks. Approved by the U.S. Food and Drug Administration in 2009, it was the first DNA test sanctioned for HPV … Read more
Human papillomavirus (HPV), distinct from HIV and HSV, stands as the most prevalent sexually transmitted disease in the United States, infecting around 14 million individuals, including teens, annually. Unlike a singular virus, HPV comprises numerous types, recognized by the warts (papillomas) they generate. While many infections resolve on their own, certain HPV strains can lead … Read more
In a significant move to combat cervical cancer, Nigeria has integrated the human papillomavirus (HPV) vaccine into its regular immunization system, with a goal of vaccinating 7.7 million girls.
A recent research study, published in The Lancet Global Health, has revealed a concerning fact – nearly 1 in 3 men aged 15 and above are currently infected with at least one type of genital human papillomavirus (HPV). What’s even more alarming is that 1 in 5 men harbor one or more high-risk, oncogenic HPV … Read more
While the dangers of smoking and excessive alcohol consumption in relation to cancer are widely known, a significant number of people remain unaware of the increasing link between oral sex and several major cancers. Startling new research reveals that less than one-third of Americans are aware that Human Papillomavirus (HPV), a common sexually transmitted infection, can lead to cancer.